Grants Search Results

This institution is a member of the Grupo América Latina de Oncología Pediátrica (GALOP). For a description of this project, see the grant made to the lead institution: Children's Oncology Group, Philadelphia, PA.

This institution is a member of the Grupo América Latina de Oncología Pediátrica (GALOP). For a description of this project, see the grant made to the lead institution: Children's Oncology Group, Philadelphia, PA.

This institution is a member of the Grupo América Latina de Oncología Pediátrica (GALOP). For a description of this project, see the grant made to the lead institution: Children's Oncology Group, Philadelphia, PA.

This institution is a member of the Grupo América Latina de Oncología Pediátrica (GALOP). For a description of this project, see the grant made to the lead institution: Children's Oncology Group, Philadelphia, PA.

This institution is a member of the Grupo América Latina de Oncología Pediátrica (GALOP). For a description of this project, see the grant made to the lead institution: Children's Oncology Group, Philadelphia, PA.

This institution is a member of the Grupo América Latina de Oncología Pediátrica (GALOP). For a description of this project, see the grant made to the lead institution: Children's Oncology Group, Philadelphia, PA.

This institution is a member of the Grupo América Latina de Oncología Pediátrica (GALOP). For a description of this project, see the grant made to the lead institution: Children's Oncology Group, Philadelphia, PA.

This institution is a member of the Grupo América Latina de Oncología Pediátrica (GALOP). For a description of this project, see the grant made to the lead institution: Children's Oncology Group, Philadelphia, PA.

This institution is a member of the Grupo América Latina de Oncología Pediátrica (GALOP). For a description of this project, see the grant made to the lead institution: Children's Oncology Group, Philadelphia, PA.

This institution is a member of the Grupo América Latina de Oncología Pediátrica (GALOP). For a description of this project, see the grant made to the lead institution: Children's Oncology Group, Philadelphia, PA.

This institution is a member of the Grupo América Latina de Oncología Pediátrica (GALOP). For a description of this project, see the grant made to the lead institution: Children's Oncology Group, Philadelphia, PA.

Through this partnership with Bermuda Cancer and Health Centre proceeds from St. Baldrick's events in Bermuda fund the SunSmart program and life-saving research through the St. Baldrick's Foundation.

This NetApp St. Baldrick's Infrastructure grant provides necessary resources to establish a database to help researchers understand potential barriers to enrollment in clinical trials, and develop interventions to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant is named for the NetApp team, whose employees around the world have raised more than $4 million for lifesaving research through the St. Baldrick's Foundation.

This grant provides resources to help build a central database of findings to be available to the pediatric cancer research community to enhance the progression of research. By linking together thousands of scientists and doctors, SAGE Bionetworks will provide tools and key information through a solution called crowd-sourcing.

This grant funds a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant funds a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant funds a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant funds a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant funds a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant helps provide necessary resources to build an early phase clinical trial program, and increase the number of such trial enrollments.